Empasug 25mg
| Brand | Empasug 25mg |
|---|---|
| Composition | Empagliflozin 25 mg IR |
| Packing | 10x10 |
| Pack Type | Tab |
For pharmaceutical trade buyers, not patient or consumer sales. This record reproduces company product information, not medical advice. Current product availability and terms are confirmed by Intra Life.
Enquire about Empasug 25mgIndication
Management of type 2 diabetes mellitus in adults, alongside diet and exercise, to improve blood glucose control.
Mechanism of action
Empagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidneys. This reduces glucose reabsorption and increases urinary glucose excretion, helping lower blood glucose.
For pharmaceutical trade information, not a patient-specific prescription. Use the current approved product insert and the prescribing clinician's directions.
Empasug 25mg for B2B enquiries
Distributors, stockists, medical stores, hospitals and PCD franchise buyers can share their city, quantity and product requirements. Ask the team for current supply, packing and trade terms.
Ask for trade details on WhatsAppKeep exploring
Browse related brand searches · All published products · Browse divisions
Explore products with a matching ingredient term
For catalogue browsing only, not substitutions. Formulations and strengths differ.
Empasug ST 100/10Empagliflozin 10 mg + Sitagliptin 100 mg
EmpaSug-SM-10-100-500srEmpagliflozin 10mg + Sitagliptin 100mg + Metformin hydrochloride 500mg
EmpaSug-SM-25-100-500srEmpagliflozin 25mg + Sitagliptin 100mg + Metformin hydrochloride 500mg
Empasug-M 500/12.5Empagliflozin 12.5 mg + Metformin 500 mg IR